Comparative Genomics for the Investigation of Autoimmune Diseases

Title: Comparative Genomics for the Investigation of Autoimmune Diseases

Volume: 12 Issue: 29

Author(s): Steffen Moller, Uwe K. Zettl, Pablo Serrano-Fernandez and Robert Goertsches

Affiliation:

Keywords: susceptibility locus (SL), DNA sequences, bioinformatics, genetic mutation, Kyoto Encyclopedia of Genes and Genomes (KEGG), Pathway Data

Abstract: The complete DNA sequence of the human genome and of several related mammals are now available, due to the investments of enormous resources and advances in sequencing technology. Novel technologies have been developed to compare multiple genomes with each other, thus specifying regions of sequence similarity among mammals and with their pathogens. Larger blocks of sequence similarity (syntenic regions) have been determined and made publicly available. In many ways, novel insights can be gained by such data when combining external genetic or clinical information for these syntenic loci. These novel tools have proven to be successful in inferring functional equivalence between loci of multiple genomes. This review reports on the role of comparative genomics in research on autoimmune diseases, a field with strong dependencies on animal models of human diseases and the problem of an adequate information transfer between multiple organisms and research areas.

Cite this article as:

Moller Steffen, Zettl Uwe K., Serrano-Fernandez Pablo and Goertsches Robert, Comparative Genomics for the Investigation of Autoimmune Diseases, Current Pharmaceutical Design 2006; 12 (29) . https://dx.doi.org/10.2174/138161206778559795